FibroBiologics Secures Australian Patent for Breakthrough Cartilage Regeneration Method

FibroBiologics, , a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the development of therapeutics and potential...

April 12, 2024 | Friday | News
Australian Biotech Firm Ferronova Initiates Clinical Trial for FerroTrace® Nanoparticle Technology in Gastric and Oesophageal Cancers

Australian biotech company Ferronova has announced the initiation of a clinical trial of the company’s FerroTrace® nanoparticle technology in pat...

April 10, 2024 | Wednesday | News
Align Technology Launches Invisalign® Palatal Expander System in Australia and New Zealand

Invisalign® Palatal Expanders offer doctors an effective and easily removable alternative to traditional palatal expanders, without the need for meta...

April 02, 2024 | Tuesday | News
Takeda's ADZYNMA® Receives Approval in Japan for Congenital Thrombotic Thrombocytopenic Purpura (cTTP)

    cTTP, an ultra-rare blood clotting disorder, presents life-threatening acute events and debilitating chronic symptoms. Untreated acute TTP ...

March 27, 2024 | Wednesday | News
MediciNova Receives Notice of Allowance for MN-166 Patent in Japan

MediciNova, Inc., a biopharmaceutical company listed on the NASDAQ Global Market (NASDAQ:MNOV) and the Tokyo Stock Exchange (Code Number: 4875), has receiv...

March 27, 2024 | Wednesday | News
Biocytogen Partners with ABL Bio to Forge Ahead in Bispecific Antibody-Active Ingredient Conjugate Development

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315), a global biotechnology company focused on the development of novel antibody the...

March 26, 2024 | Tuesday | News
Merck Commits Over €300 Million to Establish Cutting-Edge Life Science Production Hub in South Korea

  Matthias Heinzel, Member of the Executive Board of Merck and CEO Life Science, emphasized the strategic importance of this move, stating, "The Asia...

March 21, 2024 | Thursday | News
Samsung Ventures Backs BrickBio to Pave the Way for Next-Generation Therapies

Samsung Ventures, a key player in the life sciences sector, has made a strategic investment in BrickBio, Inc., a preclinical-stage biopharmaceutical compan...

March 19, 2024 | Tuesday | News
Australia's Telix Pharmaceuticals Forges Alliance to Drive Personalized Cancer Treatment

Telix Pharmaceuticals Limited (ASX: TLX) has announced a strategic agreement to partner with ABX-CRO Advanced Pharmaceutical Services Forschungsgesellschaf...

March 19, 2024 | Tuesday | News
Novartis Expands Biopharmaceutical Manufacturing Site in Singapore

The expanded facility will focus on manufacturing therapeutic antibody drugs, contributing to the delivery of breakthrough treatments to patients globally....

March 18, 2024 | Monday | News
Fennec and Norgine Partner to Commercialize PEDMARQSI in Europe, Australia, and NZ

Agreement pairs Norgine’s commercial expertise and leading European footprint with PEDMARQSI®, the first and only approved therapy in the Europea...

March 18, 2024 | Monday | News
Beckman Coulter and Fujirebio to Develop Blood-based Neurodegenerative Disease Diagnostics

  In 2023, Beckman Coulter and Fujirebio entered into a collaboration agreement focused on new biomarkers aligned with recently approved monoclonal a...

March 13, 2024 | Wednesday | News
Registration Now Open for BIO Asia–Taiwan 2024: A Keystone Event for Asia's Biotech Industry

  The highly anticipated BIO Asia–Taiwan 2024 has officially opened its registration for attendees. Scheduled to take place from July 24 to 28 ...

February 26, 2024 | Monday | News
Daiichi Sankyo and AstraZeneca's Datopotamab Deruxtecan BLA Accepted in U.S. for Advanced Nonsquamous NSCLC Treatment

Daiichi Sankyo (TSE: 4568) and AstraZeneca (LSE/STO/Nasdaq: AZN) have announced the acceptance of their Biologics License Application (BLA) for datopotamab...

February 19, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close